4'-(4-Chlorophenyl)-2,2':6',2''-terpyridine, 97%, 250mg

2-Fluoro-5-(trifluoromethyl)benzonitrile>98.0%(GC)5g

Diethyl (4-bromophenyl)phosphonate, 97%, 1g

6-Boc-1,4,5,7-tetrahydropyrazolo[3,4-c]pyridine-3-carboxylic acid, 95.0%, 25g

Oxyde de bismuth(III), min 99,5 %, pa, 100 g, emballage plastique.

7-(Diethylamino)-3-(1-methyl-1H-benzo[d]imidazol-2-yl)-2H-chromen-2-one, 95.0%, 250mg

2-(5-Fluoro-1H-benzoimidazol-2-yl)-ethylamine, 95.0%, 5g

Ethyl 1H-indazole-4-carboxylate, 95.0%, 5g

5-BROMO-2-CHLOROISONICOTINONITRILE, 95.0%, 100mg

(S)-6-Bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, 98%, 500mg

tert-Butyl ((1S,3R)-3-hydroxycyclopentyl)carbamate, 95.0%, 100g

(6-Chloro-2-methanesulfonyl-pyrimidin-4-yl)-cyclopropyl-amine, 2g

ethyl 4-(acetoacetylamino)benzoate, 95.0%, 1g